A new paraneoplastic encephalomyelitis autoantibody reactive with the axon initial segment

Area of Science:

• Neuroimmunology
• Oncology
• Cell Biology

Background:

• Paraneoplastic encephalomyelitis (PEM) is a rare autoimmune disorder often associated with small cell lung cancer (SCLC).
• Autoantibodies targeting neuronal components can cause severe neurological dysfunction in PEM.
• Identifying specific autoantigens is crucial for understanding disease mechanisms and developing targeted therapies.

Observation:

• Serum from a patient with PEM and SCLC exhibited high-titer staining of the axon initial segment (AIS) in rat and human brain tissues.
• Electron microscopy localized the target antigen near microtubules within the AIS.
• Distinct staining patterns differentiated the antigen from previously identified AIS proteins like betaIV spectrin.

Findings:

• The study excluded betaIV spectrin as the autoantigen based on double labeling and lack of staining at the nodes of Ranvier.
• Screening identified ubiquitin-conjugating enzyme E2E1 (UBE2E1) as a potential candidate.
• Further experiments ruled out UBE2E1 as the specific autoantigen targeted in this patient's serum.

Implications:

• This research points to a novel, yet unidentified, autoantigen in the AIS associated with SCLC-related PEM.
• Further characterization of this antigen is necessary to elucidate its role in neuroinflammation and neuronal function.
• The findings contribute to the ongoing effort to diagnose and treat paraneoplastic neurological disorders.